MICALE, Vincenzo, Jana KUČEROVÁ and Alexandra ŠULCOVÁ. Leading compounds for the validation of animal models of psychopathology. CELL AND TISSUE RESEARCH. Heidelberg: Springer Verlag, 2013, vol. 354, No 1, p. 309-330. ISSN 0302-766X. Available from: https://dx.doi.org/10.1007/s00441-013-1692-9.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Leading compounds for the validation of animal models of psychopathology
Authors MICALE, Vincenzo (380 Italy, belonging to the institution), Jana KUČEROVÁ (203 Czech Republic, belonging to the institution) and Alexandra ŠULCOVÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition CELL AND TISSUE RESEARCH, Heidelberg, Springer Verlag, 2013, 0302-766X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.333
RIV identification code RIV/00216224:14740/13:00071642
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1007/s00441-013-1692-9
UT WoS 000325103500025
Keywords in English Depression; Schizophrenia; Animal models; Antipsychotics; Antidepressants
Tags ok, rivok
Tags International impact, Reviewed
Changed by Changed by: Olga Křížová, učo 56639. Changed: 13/2/2014 09:31.
Abstract
Modelling of complex psychiatric disorders, e.g., depression and schizophrenia, in animals is a major challenge, since they are characterized by certain disturbances in functions that are absolutely unique to humans. Furthermore, we still have not identified the genetic and neurobiological mechanisms, nor do we know precisely the circuits in the brain that function abnormally in mood and psychotic disorders. Consequently, the pharmacological treatments used are mostly variations on a theme that was started more than 50 years ago. Thus, progress in novel drug development with improved therapeutic efficacy would benefit greatly from improved animal models. Here, we review the available animal models of depression and schizophrenia and focus on the way that they respond to various types of potential candidate molecules, such as novel antidepressant or antipsychotic drugs, as an index of predictive validity. We conclude that the generation of convincing and useful animal models of mental illnesses could be a bridge to success in drug discovery.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 27/4/2024 02:36